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Interstitial pneumonia and pulmonary 
hypertension associated with suspected 
ehrlichiosis in a dog
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Abstract 
Background: In dogs with canine monocytic ehrlichiosis (CME), respiratory signs are uncommon and clinical and 
radiographic signs of interstitial pneumonia are poorly described. However, in human monocytic ehrlichiosis, respira-
tory signs are common and signs of interstitial pneumonia are well known. Pulmonary hypertension (PH) is classified 
based on the underlying disease and its treatment is aimed at reducing the clinical signs and, if possible, addressing 
the primary disease process. PH is often irreversible, but can be reversible if it is secondary to a treatable underlying 
etiology. CME is currently not generally recognized as one of the possible diseases leading to interstitial pneumonia 
and secondary PH in dogs. Only one case of PH associated with CME has been reported worldwide.
Case presentation: A seven-year-old, male intact, mixed breed dog was presented with 2 weeks history of lethargy 
and dyspnea. The dog previously lived in the Cape Verdean islands. Physical examination showed signs of right-sided 
congestive heart failure and poor peripheral perfusion. Thoracic radiography showed moderate right-sided cardio-
megaly with dilation of the main pulmonary artery and a mild diffuse interstitial lung pattern with peribronchial cuff-
ing. Echocardiography showed severe pulmonary hypertension with an estimated pressure gradient of 136 mm Hg. 
On arterial blood gas analysis, severe hypoxemia was found and complete blood count revealed moderate regenera-
tive anemia and severe thrombocytopenia. A severe gamma hyperglobulinemia was also documented. Serology for 
Ehrlichia canis was highly positive. Treatment with oxygen supplementation, a typed packed red blood cell transfu-
sion and medical therapy with doxycycline, pimobendan and sildenafil was initiated and the dog improved clinically. 
Approximately 2 weeks later, there was complete resolution of all clinical signs and marked improvement of the PH.
Conclusion: This report illustrates that CME might be associated with significant pulmonary disease and should be 
considered as a possible differential diagnosis in dogs presenting with dyspnea and secondary pulmonary hyperten-
sion, especially in dogs that have been in endemic areas. This is important because CME is a treatable disease and its 
secondary lung and cardiac manifestations may be completely reversible.
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Background
Ehrlichia canis is a pleomorphic bacterium that infects 
circulating monocytes and can cause canine mono-
cytic ehrlichiosis (CME). CME results in variable non-
specific clinical manifestations and clinical signs can 
be subclinical, acute or chronic. Most dogs present 
with depression, lethargy, mild weight loss, anorexia, 
splenomegaly, and lymphadenopathy with or without 
hemorrhagic tendencies [1, 2]. Respiratory signs are spo-
radically reported in dogs but are regularly described in 
human patients infected with human monocytic ehrli-
chiosis (HME) [3].
Interstitial pneumonia can have an infectious or non-
infectious etiology. In dogs, reported infectious agents 
leading to interstitial pneumonia are Angiostrongylus 
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vasorum, Leishmania chagasi, Toxoplasma gondii, 
Pneumocystis carinii, Babesia canis, Leptospira sp., 
Mycoplasma sp, canine distemper virus and adenovi-
rus [4–12]. In patients with interstitial pneumonia, gas 
exchange is often impaired due to ventilation-perfusion 
mismatching, intrapulmonary shunting, and decreased 
diffusion across the abnormal interstitium with arterial 
hypoxia as a consequence. In contrast to the systemic 
vasculature that responds with arterial vasodilation to 
better perfuse hypoxic tissue, the pulmonary vasculature 
constricts in response to hypoxia. Besides pulmonary 
vasoconstriction, hypoxia also causes proliferation of the 
smooth muscle cells in the arterial wall. Both phenom-
ena lead to a decrease in luminal cross-sectional area and 
an increase in pulmonary vascular resistance index with 
pulmonary hypertension (PH) as a consequence.
Pulmonary hypertension is classified based on the 
underlying disease and its treatment is aimed at improv-
ing the clinical signs and addressing the primary disease 
process [13]. Although PH is often irreversible, PH is 
reversible in some cases if the underlying etiology is diag-
nosed and treated accordingly. Reversibility of PH has 
for instance been demonstrated in dogs after successful 
treatment for A. vasorum [14].
Pulmonary changes consistent with interstitial pneu-
monia have been reported previously in humans with 
HME [3] and as an atypical finding in dogs with CME 
[15–18]. However, CME is generally not recognized as 
one of the possible diseases leading to interstitial pneu-
monia and secondary PH in dogs. Only one case of PH 
associated with E. canis infection has been reported 
worldwide [19]. Consequently, CME might be underdiag-
nosed as a possible cause of interstitial pneumonia and 
secondary PH.
This case report describes the clinical, radiographic 
and echocardiographic presentation of a dog with inter-
stitial pneumonia and severe PH suspected to be associ-
ated with E. canis infection.
Case presentation
A seven-year-old, intact male, mixed breed dog weigh-
ing 8.1  kg was presented to the Emergency Service of 
the Department of Clinical Science of Companion Ani-
mals of the Faculty of Veterinary Medicine, Utrecht 
University with a 2  weeks history of lethargy, progres-
sive dyspnea and coughing. The dog previously lived in 
the Cape Verdean islands for approximately 3 years and 
returned to the Netherlands 10 months before presenta-
tion. In the past 2  years, the dog had showed chronic 
mild exercise intolerance and had a few episodes of 
diarrhea that resolved with symptomatic therapy. The 
dog was up-to date with his vaccinations and anthel-
minthic treatments.
Physical examination showed generalized weakness 
and decrease mental state. Cardiovascular examina-
tion revealed tachycardia, weak peripheral pulses, pale 
mucous membranes, prolonged capillary refill time, jugu-
lar distensions and venous pulses, and a grade three out 
of six systolic murmur with the point of maximal inten-
sity over the right cardiac apex. The dog was also severely 
dyspneic and demonstrated harsh lung sounds on auscul-
tation. The abdomen was distended and positive undula-
tion was detected. These findings were consistent with 
pulmonary disease, right-sided heart failure and poor 
peripheral perfusion.
Complete blood count (CBC) showed a moderate 
microcytic, hypochromic anemia, moderate leukocyto-
sis with a marked left shift and a severe thrombocyto-
penia. Biochemistry showed severe hyperproteinemia, 
hyperglobulinemia and a mild hypoalbuminemia. Serum 
protein electrophoresis showed a polyclonal peak in 
the gamma globulin region. Arterial blood gas analysis 
showed a severe hypoxemia with hypocapnia. Urinaly-
sis showed mild hemoglobinuria, glucosuria and pro-
teinuria. Blood samples were submitted for serological 
and molecular biological testing. Immunofluorescence 
antibody test (IFAT) for E. canis (MegaFLUO Ehrlichia 
canis®, Mega Cor Diagnostik GmbH, Hörbranz, Aus-
tria) was positive (IgG titer >2560), but polymerase chain 
reaction (PCR) amplification for Ehrlichia genus (real-
time PCR, Light Cycler® 2.0, Roche Diagnostics GmBH, 
Mannheim, Germany, primers used as described previ-
ously [20]) was negative. Serology for Leishmania sp. 
(Dog-DAT®, Leishmania specific antibody detection kit, 
Koninklijk Instituut voor de Tropen, Amsterdam, the 
Netherlands) and B. canis. (MegaFLUO Babesis canis®, 
Mega Cor Diagnostik GmbH, Hörbranz, Austria) and 
antigen snap tests for A. vasorum (Angio Detect™ Test, 
IDEXX Laboratories) and Dirofilaria immitis (SNAP® 
Heartworm RT Test, IDEXX Laboratories) were also neg-
ative. Laboratory results are summarized in Table 1.
On thoracic radiographs, a mild diffuse increase in 
pulmonary opacity with an interstitial lung pattern and 
mild peribronchial cuffing was seen, which was most 
accentuated in the caudodorsal lung lobes. Thin pleural 
fissure lines were noted between all lung lobes. The car-
diac silhouette showed signs of right-sided cardiomegaly 
(vertebral heart score (VHS): 11.0, reference interval 
<9.7  ±  0.5) and a main pulmonary artery knuckle was 
present on the dorsoventral view (Fig. 1).
Echocardiography showed dilation of the right ven-
tricle and the pulmonary artery, septal flattening and 
a severe tricuspid regurgitation. The left ventricle was 
severely under filled (Fig. 2). Congenital defects and left 
heart disease were excluded. The maximal tricuspid sys-
tolic velocity was 5.83  m/s, indicating a peak tricuspid 
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gradient of approximately 136  mm Hg which is graded 
as severe PH (reference <40 mm Hg, severe >75 mm Hg) 
[13], (Fig. 3).
To address the severe hypoxemia and PH the dog was 
placed in an oxygen cage with an inspired concentra-
tion of oxygen between 40 and 50  %. The clinical signs 
of the dog did not improve markedly with the extra 
oxygen supplementation. Because anemia could have 
contributed to the cardiovascular signs and the poor tis-
sue oxygenation, a typed packed red blood cell transfu-
sion was administered. Based on the travel history, the 
abnormalities within the CBC and biochemical analysis 
and the positive serology for E. canis, an infection with 
CME was suspected. Treatment with doxycycline (5 mg/
kg, orally twice daily) (Doxoral®, AST Farma, Oudewa-
ter, the Netherlands), pimobendan (0.3  mg/kg, orally 
twice daily) (Cardisure® Flavour, Eurovet Animal Health 
BV, Bladel, the Netherlands) and sildenafil (1.5  mg/kg, 
orally twice daily) (Viagra®, Pfizer, New York, USA) was 
initiated.
The hematocrit increased from 20 to 36  % after the 
blood transfusion and the dog’s clinical condition 
improved remarkably. However, the dog remained mod-
erately dyspneic and severely hypoxic (PaO2: 46.5  mm 
Hg, reference interval: 85.0–103.3 mm Hg). The dyspnea 
gradually improved and the dog seemed comfortable out-
side the oxygen cage after 6 days of treatment, although 
the improvement of the hypoxemia was only minimal 
(PaO2: 55 mm Hg, reference interval: 85–103.3 mm Hg, 
Table  1). Because of financial limitations of the owner, 
the dog was discharged with the above-mentioned thera-
pies at that time.
Seventeen days after initiation of treatment, the dog was 
admitted via the cardiology polyclinics of the same uni-
versity and re-examined. At that time, there was complete 
resolution of all clinical signs and physical examination 
was completely unremarkable. CBC showed normal plate-
let counts and leukogram, with only a very mild microcytic 
hypochromic anemia. Biochemical analysis again showed 
severe hyperproteinemia and hyperglobulinemia. The 
Table 1 Summary of haematological, biochemical, serological and urine and blood gas analysis results
Arterial blood gas analysis was performed with an inspired concentration of oxygen of 21 %
Values in italics are outside the reference interval
MCV mean corpuscular volume, MCHC mean corpuscular hemoglobin concentration, MCH mean corpuscular hemoglobin, WBC white blood cell count, UPC urinary 
protein to creatinine ratio, PaO2 partial arterial oxygen pressure, PaCO2 partial arterial carbon dioxide pressure, BE base excess
Parameter Day 1 Day 7 Day 17 Day 50 Reference interval
Hematocrit (L/L) 0.20 0.38 0.40 0.34 0.42–0.61
MCV (fl) 57.7 59.9 59.9 63.5–72.9
MCHC (mmol/L) 21.7 21.8 22.2 20.5–22.4
MCH (fmol) 1.25 1.31 1.33 1.37–1.57
Total WBC (×109/L) 23.1 6.6 6.7 4.5–14.6
Segmented neutrophils (×109/L) 17.3 2.6 4.4 2.9–11.0
Band neutrophils (×109/L) 3.2 0.0 0.0 0.0–0.3
Lymphocytes (×109/L) 2.1 3.0 1.8 0.8–4.7
Monocytes (×109/L) 0.5 0.4 0.3 0.0–0.9
Eosinophils (×109/L) 0.0 0.5 0.2 0.0–1.6
Platelets (×109/L) 15 251 166 144–603
Urea (mmol/L) 4.1 7.0 3.0–12.5
Creatinine (µmol/L) 33 74 77 50–129
Sodium (mmol/L) 145 145 141 141–150
Potassium (mmol/L) 4.1 4.7 3.7 3.6–5.6
Total protein (g/L) 91 119 89 55–72
Albumin (g/L) 16 27 26 26–37
Gamma-globulins (g/L) 57 68 40 3–9
UPC 0.8 0.3 <0.5
PH 7.45 7.49 7.35–7.45
PaO2 (mm Hg) 48 55 85–103.3
PaCo2 (mm Hg) 19.8 32 32–43
BE −9 1.4 −2 to +2
Lactate (mmol/L) 2.6 1.3 <2.5
IgG titer Ehrlichia Canis >1:2560 1:2560 <1:40
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albumin concentration normalized. The IgG titer for E. 
canis (IFAT) was again very high (IgG titer 2560) (Table 1). 
Thoracic radiography showed marked improvement with 
resolution of cardiomegaly (VHS: 10.2, reference interval 
9.7 ± 0.5) and only a very mild interstitial pattern of the 
caudodorsal lung lobes and a very mild dilation of the pul-
monary artery (Fig. 4) as remaining abnormalities. Echo-
cardiography also showed a remarkable improvement. 
Tricuspid regurgitation was no longer present and only a 
very mild uniform dilation of the pulmonary artery was 
Fig. 1 Right lateral (a) and dorsoventral (b) thoracic radiographs at presentation. Radiographs demonstrating right-sided enlargement of the car-
diac silhouette (vertebral heart score: 11.0, reference interval <9.7 ± 0.5), mild dilation of the pulmonary arteries and a mild increase in lung opacity 
with a diffuse interstitial lung pattern and peribronchial cuffing
Fig. 2 Echocardiographic images at presentation from right parasternal short axis view. a Two-dimensional view demonstrating severe right 
ventricular (RV) dilation, flattening of the interventricular septum (IVS) and a hypovolemic left ventricle (LV). b M-mode view demonstrating severe 
right ventricular dilation, a hypovolemic left ventricle and paradoxical motion of the interventricular septum. c Two-dimensional view of pulmonary 
artery (PA) and aorta (AO). The PA is uniformly dilated and is wider than the Aorta with a PA/AO ratio of 1.3 (reference interval: 0.8–1.15)
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still present (Fig. 5). Therapy with pimobendan and silde-
nafil were discontinued and the treatment with doxycy-
cline was continued for another 5 weeks.
The dog was reevaluated 4  weeks later and was clini-
cally doing very well. Nevertheless, the dog again devel-
oped mild anemia and the hyperproteinemia persisted. 
Proteinuria had resolved at that time (Table  1). Doxy-
cycline therapy was continued for another 4  weeks and 
another re-examination was advised. Unfortunately, the 
dog was lost to follow–up at that time.
Conclusion
Interstitial pneumonia with secondary PH was suspected 
in this dog based on the presentation on thoracic radiog-
raphy and the severe hypoxemia on arterial blood gas, but 
the etiology was initially unclear. However, CME was sus-
pected based on the travel history of the dog, the results 
of CBC, biochemical analysis and a positive serology 
result for E. canis. Exposure to E. canis was demonstrated 
with the IFAT for anti-E. canis IgG antibodies. IgG titers 
>40 are considered positive for E. canis exposure [21]. In 
Fig. 3 Echocardiographic images at presentation from left apical 4-chamber view. a color Doppler map of severe tricuspid regurgitation. RA right 
atrium, RV right ventricle, LA left atrium, LV left ventricle. b spectral Doppler trace of tricuspid regurgitation. Tricuspid systolic velocity of 5.8 m/s, indi-
cating a peak tricuspid pressure gradient of approximately 136 mm Hg, graded as severe pulmonary hypertension (reference <40 mm Hg, severe 
>75 mm Hg
Fig. 4 Right lateral (a) and dorsoventral (b) thoracic radiographs 2 weeks after discharge. Radiographs demonstrating resolution of cardiomegaly 
(vertebral heart score: 10.2, reference interval <9.7 ± 0.5) and reduction of the dilation of pulmonary arteries and the diffuse interstitial pattern
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this case, the IgG titer was high (>2560), which strength-
ened the suspicion of an active infection [22].
However, definite active infection at the time of pres-
entation could not be proven, because PCR amplifica-
tion for Ehrlichia genus was negative and anti-Ehrlichial 
IgG antibodies persist for several months to years after 
elimination of the parasite [23]. A negative result from 
a PCR test can occur when organisms in circulation are 
below the level of detection, as may happen when infec-
tions are chronic. It has been demonstrated that dogs can 
be PCR negative on blood samples, but PCR positive on 
splenic aspirates [21]. It is hypothesized that the E. canis 
are sequestered in splenic macrophages to avoid immune 
elimination. Unfortunately, in the present case, the own-
ers declined fine needle aspirates of the spleen due to the 
potential risks and stress involved, e.g. internal bleeding, 
aggravation of the dyspnea. Paired serology samples can 
also provide useful information about antibody kinetics, 
which may point to current status of infection. A four-
fold increase in IgG antibodies over time is suggested to 
be evidence for an active infection [24]. Antibody titers 
will decrease gradually after appropriate treatment, but 
may persist for months to years even after full clini-
cal recovery [23, 25]. In this case, the Ehrlichia IgG titer 
was still very high 17 days after initiation of doxycycline 
therapy, probably due to the short time between start of 
the treatment and retesting; IFAT was unfortunately not 
repeated on day 50.
Although doxycycline therapy generally results in fast 
clinical improvement and improvement of most labora-
tory abnormalities, persistence of hyperglobulinemia is 
generally observed for a longer period. Most studies have 
shown normalization of serum protein electrophoresis 
results after 3–9 months of therapy [1, 15]. This explains 
the persistence of hyperglobulinemia at the re-examina-
tions of the dog at days 17 and 50.
In human medicine, respiratory signs are commonly 
described as a consequence of HME infection [3] and 
acute respiratory distress syndrome (ARDS) has also been 
reported as a severe, although uncommon, finding in 
HME [26–28]. Both CME and HME animal models also 
revealed prominent mononuclear cellular infiltration in 
the interalveolar septa, endothelial damage and vasculi-
tis in the lungs [16, 29]. This could explain the pulmonary 
changes found in this dog and the clinical and radio-
graphic improvement after treatment with doxycycline. 
However, recently, acute resolution of patchy pulmonary 
alveolar infiltrates has been described after sildenafil 
therapy in dogs with idiopathic PH and PH secondary to 
idiopathic lung fibrosis [30]. Therefore, sildenafil therapy 
might also have contributed to the improvement of the 
radiographic changes in this case. Another explanation 
Fig. 5 Echocardiographic images obtained 2 weeks after treatment from right parasternal short axis view. a, b: Two-dimensional (a) and M-mode 
(b) view demonstrating normalization of cardiac dimensions and function. c Two-dimensional view of pulmonary artery (PA) and aorta (AO). The PA 
is uniformly minimally dilated with a PA/Ao ratio of 1.2 (reference interval: 0.8–1.15)
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for the radiographic abnormalities and the improvement 
on doxycycline therapy that cannot be excluded is that the 
dog suffered from a bacterial pneumonia.
Furthermore, an important possible factor that might 
have contributed to the hypoxemia and PH in this dog 
is pulmonary thromboembolism (PTE) [31]. PTE can 
occur as complicating sequelae in patients with PH 
or can be the primary cause of PH [32]. In people, it is 
increasingly recognized that patients with pulmonary 
arterial hypertension have dysregulated coagulation and 
antithrombotic homeostasis, which may contribute to 
a prothrombotic state [33]. Unfortunately, we did not 
perform diagnostic investigations such as D-dimer con-
centration [34], computed tomography pulmonary angi-
ography [35] or thromboelastography (TEG) [36, 37] to 
investigate if the dog suffered from PTE or a prothrom-
botic state. However, to the author’s knowledge, PTE has 
never been associated with CME in veterinary literature. 
Only two cases of aortic and portal vein thrombosis have 
been described in dogs with CME [38, 39].
Treatment of PH is aimed at eliminating or improving 
the underlying disease process. If the PH is not controlled 
by primary disease therapy or if the PH is idiopathic, 
treatment with pulmonary arterial dilators may be imple-
mented. In veterinary medicine currently, only phos-
phodiesterase inhibitors are used. Sildenafil is a highly 
selective phosphodiesterase five inhibitor that has been 
used in veterinary medicine with encouraging results 
[30, 40]. Pimobendan, a calcium-sensitizing agent with 
phosphodiesterase three inhibiting actions has also been 
used, especially when left heart disease is a contributing 
cause [41]. In the present case, a dual therapy with pul-
monary arterial dilators was initiated, because we hoped 
this would ameliorate the very severe PH and clinical 
signs faster than a monotherapy with sildenafil. Although 
recovery has been described in a similar case with just a 
monotherapy with doxycycline [19], we believe that the 
symptomatic support with pulmonary vasodilators was 
justified in this dog. Mild to moderate improvement of 
tricuspid regurgitation gradient by sildenafil therapy has 
been described in some dogs with PH [30], but not in 
others [42]. Consequently, we cannot rule out that the 
improvement of the echocardiographic changes could 
also be partially explained by the use of the vasodilating 
drugs. Ideally, another echocardiogram should have been 
performed after discontinuation of the vasodilator ther-
apy. However, the improvement was so dramatic, that we 
do not believe that this could be solely explained by the 
vasodilator therapy.
This case report illustrates that CME might be asso-
ciated with significant pulmonary disease and that it 
should be considered as a possible differential diag-
nosis in dogs presenting with dyspnea and secondary 
pulmonary hypertension, especially in dogs that have 
been in endemic areas. This is important because CME 
is a treatable disease and its lung and cardiac manifesta-
tions may be completely reversible.
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